PPARA and fatty liver disease: PPAR-α is another AMPK downstream target and is crucial for hepatic lipid oxidation and export (Silva and Peixoto, 2018), its activation leads to the improvement of liver steatosis, inflammation and fibrosis in rodent model (Staels et al., 2013).